Table 2. Prevalences (%) of comorbid conditions at baseline by continenta

EuropeJapanP-valuebUSP-valueb
a See Appendix for definitions of comorbid conditions.
b P-value for comparison with Europe.
Coronary artery disease29.419.2<0.00149.8<0.001
Congestive heart failure25.06.1<0.00145.8<0.001
Other cardiac disease36.523.9<0.00136.30.89
Left ventricular hypertrophy55.228.1<0.00134.4<0.001
Cardiomegaly by x-ray34.429.4<0.00134.90.67
Hypertension72.755.9<0.00183.2<0.001
Cerebrovascular disease13.712.50.2218.4<0.001
Peripheral vascular disease22.511.5<0.00126.10.01
Diabetes mellitus20.125.6<0.00145.7<0.001
Lung disease10.71.4<0.00113.00.005
Dyspnea19.82.7<0.00129.6<0.001
Smoking16.624.7<0.00117.60.34
Cancer9.05.3<0.0019.60.42
HIV/AIDS0.20.00.051.1<0.001
Gastrointestinal bleed5.23.60.019.9<0.001
Peptic ulcer disease17.69.3<0.00116.20.14
Hepatitis B4.12.2<0.0012.4<0.001
Hepatitis C11.513.40.047.4<0.001
Neurological disorder6.14.0<0.00112.4<0.001
Psychiatric disease24.72.5<0.00124.20.67
Recurrent cellulitis or gangrene6.42.1<0.00111.3<0.001
Vision problems31.217.9<0.00127.6<0.001
Deep venous thrombosis4.90.5<0.0013.2<0.001
Carpal tunnel syndrome7.810.8<0.0014.9<0.001
Beta-2-microglobulin disease7.414.8<0.0011.3<0.001